| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.39 | 2e-14 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |